These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 29146244)

  • 1. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.
    Kapadia CH; Tian S; Perry JL; Luft JC; DeSimone JM
    Mol Pharm; 2016 Oct; 13(10):3381-3394. PubMed ID: 27551741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
    Cuzzubbo S; Banissi C; Rouchon MS; Tran T; Tanchot C; Tartour E; Carpentier AF
    Cancer Immunol Immunother; 2020 Dec; 69(12):2501-2512. PubMed ID: 32561966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
    Karan D; Krieg AM; Lubaroff DM
    Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity.
    Pan H; Yu S; Zhuang H; Yang H; Jiang J; Yang H; Ren S; Luo G; Yu X; Chen S; Lin Y; Sheng R; Zhang S; Yuan Q; Huang C; Zhang T; Li T; Ge S; Zhang J; Xia N
    Cancer Immunol Res; 2024 Jul; 12(7):905-920. PubMed ID: 38631019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
    J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy.
    Song H; Su Q; Nie Y; Zhang C; Huang P; Shi S; Liu Q; Wang W
    Acta Biomater; 2023 Mar; 158():535-546. PubMed ID: 36632876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
    Wang K; Yang Y; Xue W; Liu Z
    Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines.
    Zhang TT; Kang TH; Ma B; Xu Y; Hung CF; Wu TC
    Vaccine; 2012 Jan; 30(4):784-93. PubMed ID: 22120194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.
    Han JA; Kang YJ; Shin C; Ra JS; Shin HH; Hong SY; Do Y; Kang S
    Nanomedicine; 2014 Apr; 10(3):561-9. PubMed ID: 24262997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
    Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
    Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
    J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing self-assembling peptide nanofibers toprime robust tumor-specific CD8 T cell responses in mice.
    Mohseninia A; Dehghani P; Bargahi A; Rad-Malekshahi M; Rahimikian R; Movahed A; Reza Farzaneh M; Mohammadi M
    Int Immunopharmacol; 2022 Mar; 104():108522. PubMed ID: 35032825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
    Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
    J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.